
Aspira Women's Health AWH
Geschäftsbericht 2025
hinzugefügt 01.04.2026
Aspira Women's Health ROCE 2011-2026 | AWH
ROCE Jährlich Aspira Women's Health
| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114.15 | 635.12 | -486.78 | -108.03 | -136.17 | -155.11 | -134.21 | -213.6 | -273.98 | -109.31 | -99.77 | -32.73 | -173.15 | -151.62 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 635.12 | -486.78 | -94.66 |
ROCE Vierteljährlich Aspira Women's Health
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5733.49 | 5815.58 | 612.57 | 1237.16 | 1713.17 | 2413.1 | 683.58 | 606.82 | -94.52 | -971.09 | -177.49 | -202.66 | -151.07 | -110.1 | -53.65 | -97.7 | -116.58 | -138.71 | -122.51 | -166.57 | -166.59 | -176.49 | -135.89 | -172.84 | -165.74 | -158.85 | -118.97 | -192.32 | -228.72 | -255.2 | -220.16 | -312.27 | -331.03 | -362.14 | -322.22 | -351.53 | -288.74 | -216.4 | -81.23 | -110.26 | -109.97 | -111.21 | -78.64 | -87.3 | -66.93 | -45.98 | -26.29 | -75.53 | -116.12 | -186.86 | -174.27 | -217.97 | -212.43 | -187.8 | -140.66 | -43.7 | -54.03 | -42.93 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5815.58 | -971.09 | 173.56 |
ROCE anderer Aktien in der Diagnostik & Forschung
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
25.0 | $ 115.54 | - | $ 35.1 B | ||
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
-236.6 | $ 1.65 | -1.26 % | $ 2.19 M | ||
|
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
1.9 | $ 24.82 | 1.47 % | $ 689 M | ||
|
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M | ||
|
CareDx, Inc
CDNA
|
-10.16 | $ 21.83 | 2.8 % | $ 1.16 B | ||
|
Illumina
ILMN
|
-35.1 | $ 128.43 | 0.43 % | $ 20.4 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
-6.52 | $ 15.71 | -3.71 % | $ 475 M | ||
|
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
28.52 | $ 84.83 | 0.59 % | $ 5.73 B | ||
|
Charles River Laboratories International
CRL
|
0.8 | $ 171.09 | 0.78 % | $ 8.48 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
116.53 | $ 421.35 | 2.63 % | $ 12.2 B | ||
|
Guardant Health
GH
|
440.3 | $ 88.83 | -0.09 % | $ 11.1 B | ||
|
Koninklijke Philips N.V.
PHG
|
6.33 | $ 27.53 | 0.22 % | $ 20 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
18.26 | $ 1.93 | -2.08 % | $ 8.54 M | ||
|
Senseonics Holdings
SENS
|
-111.94 | $ 7.25 | 2.84 % | $ 303 M | ||
|
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | ||
|
Soleno Therapeutics
SLNO
|
2.09 | $ 52.76 | 0.08 % | $ 2.68 B | ||
|
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
-51.22 | $ 9.57 | 0.31 % | $ 2.08 B | ||
|
Biomerica
BMRA
|
-125.14 | $ 2.15 | 0.7 % | $ 4.94 M | ||
|
Thermo Fisher Scientific
TMO
|
14.5 | $ 468.04 | -0.33 % | $ 176 B | ||
|
National Research Corporation
NRC
|
161.47 | $ 17.22 | -0.06 % | $ 385 M | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 102.45 | 0.27 % | $ 8.45 B | ||
|
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 263.7 | -0.02 % | $ 21.9 B | ||
|
Trinity Biotech plc
TRIB
|
0.08 | $ 0.64 | -0.82 % | $ 61.9 M | ||
|
Celcuity
CELC
|
-171.24 | $ 124.51 | 2.88 % | $ 5.82 B | ||
|
Twist Bioscience Corporation
TWST
|
-28.81 | $ 61.27 | 0.54 % | $ 3.66 B | ||
|
OpGen
OPGN
|
4.4 | - | -16.95 % | $ 1.54 M | ||
|
NeoGenomics
NEO
|
-9.11 | $ 8.56 | 3.26 % | $ 1.1 B | ||
|
Myriad Genetics
MYGN
|
-105.22 | $ 4.82 | 0.73 % | $ 446 M | ||
|
Natera
NTRA
|
-76.66 | $ 204.36 | 0.3 % | $ 20.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 196.01 | -0.1 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | ||
|
PerkinElmer
PKI
|
4.92 | - | -0.91 % | $ 14.7 B |